• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Doug Kass
    • Bruce Kamich
    • Jim Cramer
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Stocks

Johnson & Johnson Is Poised (Again) for an Upside Breakout

In this market, winning stocks 'stick out like a sore thumb.'
By BRUCE KAMICH
Jul 15, 2020 | 09:54 AM EDT
Stocks quotes in this article: CLX, JNJ

In a recent Real Money column Jim Cramer said it's not always easy to spot the rotations driving this market. But Cramer says he likes to use a "Sore Thumb Index" where the winning stocks "stick out like a sore thumb."

Among the stand-out stocks on Tuesday were several recession names including The Clorox Company (CLX) and Johnson & Johnson (JNJ) . Let's check out the charts of Action Alerts PLUS holding JNJ as the company gets set to report earnings Thursday.

In the daily bar chart of JNJ, below, we can see that prices made a new 2020 high in late April but that strength faded and prices weakened into late June. JNJ has turned upward again in recent days breaking the downtrend from late April. Prices are above the declining 50-day moving average line and above the rising 200-day moving average line.

The trading volume has been declining from the pace seen in March. The On-Balance-Volume (OBV) line has moved sideways from March and suggests a balance between aggressive buyers and aggressive sellers. If we see the OBV line move above its June highs it will be a positive development.

The Moving Average Convergence Divergence (MACD) oscillator is just slightly below the zero line but not far from an upside cross of the zero line so a crossover buy signal could happen soon.

In the weekly bar chart of JNJ, below, we can see a generally positive picture. Prices are above the rising 40-week moving average line.

The weekly OBV line has been strong since late 2018 and is not far from making a new high. The MACD oscillator is narrowing and is close to a fresh outright buy signal.

In this daily Point and Figure chart of JNJ, below, we can see a potential upside price target of $168.

In this weekly close only Point and Figure chart of JNJ, below, we can see a potential longer-term price target in the $217 area.

Bottom-line strategy: JNJ looks ready to break out to new highs. Go long on strength above $150.93 risking a close below $143. Our price targets are $168, $200 and $217.

(Johnson & Johnson and Clorox are holdings in Jim Cramer's Action Alerts PLUS member club. Want to be alerted before Jim Cramer buys or sells these stocks? Learn more now.)

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are prohibited from trading individual securities.

Action Alerts PLUS, which Cramer manages as a charitable trust, is long JNJ and CLX.

TAGS: Earnings | Investing | Stocks | Technical Analysis | Health Care Equipment & Services | Healthcare | Pharmaceuticals | Mad Money

More from Stocks

In This Market, If You Can't Beat 'Em, Join 'Em

James "Rev Shark" DePorre
Jan 26, 2021 5:50 PM EST

There is no way to know how long this theme of strong small-cap speculation and short squeezes will continue, but I have no interest in fighting it.

Is Live Ventures Taking Notes From GameStop?

Bruce Kamich
Jan 26, 2021 3:09 PM EST

Let's see what we might glean from the charts.

Before Punching the Clock, Here's an Uber Trade

Mark Sebastian
Jan 26, 2021 3:08 PM EST

The writing is on the wall for the gig economy, but I see a play in this name.

Ranpak Holdings May Double or More in 2021

Bruce Kamich
Jan 26, 2021 2:35 PM EST

Here's what aggressive traders should look for.

Jim Cramer: Ready, Set, Go!

Jim Cramer
Jan 26, 2021 1:30 PM EST

Here's why you should wait for a dip -- not the vaccine glut -- to start buying.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 09:35 AM EST CHRIS VERSACE

    Another Big Winner for Stocks Under $10

    We're ringing the register Tuesday morning.
  • 08:05 AM EST GARY BERMAN

    Tuesday Morning Fibocall for 1/26/2021

    SPX (Long-Term View) The 1/21/21 NEW high @ 3861...
  • 09:52 AM EST GARY BERMAN

    INDU/DIA 20 DMA

    Fibocall: The DIA has the 20 DMA @ 307.81 and w...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2021 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login